• 9 Hits
  • Search Condition : Filter (MeSH = Pluripotent Stem Cells / drug effects*)
Species Resource Title
Human and Animal Cells 201B7(HPS0063) Selective Elimination of Human Induced Pluripotent Stem Cells Using Medium with High Concentration of L-Alanine.
Human and Animal Cells 253G1(HPS0002) , 201B7(HPS0063) Enrichment of Pluripotent Stem Cell-Derived Hepatocyte-Like Cells by Ammonia Treatment.
Medaka TG870 Tg(olvas-GFP) Diethylnitrosamine-induced expression of germline-specific genes and pluripotency factors, including vasa and oct4, in medaka somatic cells.
Human and Animal Cells C2C12(RCB0987) Calcium ions released from mineral trioxide aggregate convert the differentiation pathway of C2C12 cells into osteoblast lineage.
Human and Animal Cells MC3T3-G2/PA6(RCB1127) Stromal factors SDF1α, sFRP1, and VEGFD induce dopaminergic neuron differentiation of human pluripotent stem cells.
Human and Animal Cells MC3T3-E1(RCB1126) , C2C12(RCB0987) Continuous inhibition of MAPK signaling promotes the early osteoblastic differentiation and mineralization of the extracellular matrix.
Human and Animal Cells C2C12(RCB0987) Effects of lactoferrin on the differentiation of pluripotent mesenchymal cells.
Human and Animal Cells 10T1/2(RCB0247) Bone morphogenetic protein 2 and dexamethasone synergistically increase alkaline phosphatase levels through JAK/STAT signaling in C3H10T1/2 cells.
Human and Animal Cells iPS-MEF-Ng-20D-17(APS0001) α₁-Adrenoceptor stimulation enhances leukemia inhibitory factor-induced proliferation of mouse-induced pluripotent stem cells.